Navigation Links
Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Date:10/18/2007

New Family of Antibacterial Products aimed at reducing cross contamination

infections including MRSA

JACKSONVILLE, Fla., Oct. 18 /PRNewswire/ -- Seal Shield Corporation announced today the SILVER SEAL(TM) family of antibacterial products for infection control. Notably, Seal Shield introduced the SILVER SEAL(TM) Antibacterial, Washable Keyboard and Mouse. According to the company, the SILVER SEAL(TM) Keyboard and Mouse are the first ever antibacterial keyboard and mouse to be fully submersible and dishwasher safe. It has been reported by Dr. William A. Rutala, University of North Carolina that washable keyboards and mice may help reduce the risk of cross contamination infections, including the "superbug," MRSA.

This year over 2 million patients will contract an infection while seeking treatment in a US hospital. Of those, close to 100,000 people will die, making hospital acquired infections a Top 10 killer of Americans. Complicating this epidemic, a strain of antibiotic resistant staph infections, MRSA, has emerged in hospitals, schools and other communal environments worldwide. Seal Shield's products have been developed in response to the demand from healthcare and education organizations for infection control solutions to combat the spread of MRSA and other cross contamination infections.

Recent studies have shown the computer keyboard and mouse to be a major source of cross contamination infections. According to Dr. Daniel LePera, "Bacteria that reside in the upper mouth or respiratory tract can travel to an in-office computer keyboard and survive as long as 24 hours. Viruses can live on them for one hour or more." A study reported at the American Society for Microbiology found that MRSA can survive on computer keyboards for up to 6 weeks.

The recent rise in hospital acquired infections, and the lack of an effective treatment for MRSA, has prompted healthcare providers to reexamine their cleaning protocols in
'/>"/>

SOURCE Seal Shield Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Protein Found to Shield Pancreatic Cancer Cells from Self-Destruction
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
5. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
6. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
7. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
10. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
11. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... (NYSE: MNK ) announced today that its ... The open-ended authorization permits the company to repurchase up ... "Funding additional initiatives and seeking attractive business ... pursue a range of focused growth strategies," said ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... a focus on Omega-3 therapies for cardiovascular disease and overall ... the Company,s accomplishments in 2014 and its outlook for 2015 ... Dear Fellow Shareholders, We would like to take ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... U.S. Food and Drug Administration has scheduled its fourth ... those unfamiliar with the process for Feb. 28 – ... Keck Graduate Institute. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... Organization of Rare Disorders and the Genetic Alliance, will ...
... /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China ... CSKI ), a leading fully integrated pharmaceutical ... today announced that Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong"), ... a "Top Ten Branded Company Trusted by Consumers" ...
Cached Medicine Technology:Fourth FDA Orphan Drug Designation Workshop Scheduled for Feb. 28 - March 1, 2011 2China Sky One Medical Receives Medical Industry Awards 2China Sky One Medical Receives Medical Industry Awards 3
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Angelweddingdress is a ... business invites its customers to follow it on Facebook, Twitter, ... a Valentine’s Day gift. Angelweddingdress draws a lottery every week. ... Sale to Feb. 28, 2015. Click Angelweddingdress homepage ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... disease carries same risk as other circulatory problems, experts ... People suffering from age-related macular degeneration (AMD) have twice ... Australian researchers report. , The degenerative eye disease is ... adults in developed countries and affects the center of ...
... Feb. 28 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; ... to the global life,sciences markets, announced that the ... Thursday, March 6., The Company will also ... President and Chief Executive Officer and Douglas Prince,Executive ...
... Eli Lilly and Company,(NYSE: LLY ) ... U.S. Food and,Drug Administration for Zyprexa(R) long-acting injection ... schizophrenia in adults, the,company announced today. Zyprexa LAI ... medication Zyprexa (olanzapine) with a,pamoate salt, resulting in ...
... First Multimedia Effort to Launch Contact Lenses in Puerto ... ... Feb. 28 Johnson & Johnson Vision,Care, today announced a multi-faceted marketing ... Brand Contact Lenses in Puerto Rico, the Caribbean and Central,America., Following ...
... Leading Specialty Toy Retailer Highlights ,Ten Toys That Speak To ... ... This weekend, Toys"R"Us, in,conjunction with the Toys"R"Us Children,s Fund, will kick off ... to facilitating research that will uncover the,causes of, develop treatments for and ...
... is more predominant in women, the reasons for this ... estrogen on the risk and severity of RA, but ... using data from the Womens Health Initiative (WHI) clinical ... no significant differences in the risk of developing RA ...
Cached Medicine News:Health News:Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk 2Health News:Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk 3Health News:FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment 2Health News:FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment 3Health News:FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment 4Health News:FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment 5Health News:FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment 6Health News:Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers 2Health News:Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers 3Health News:Toys'R'Us Kicks Off Fundraising Campaign to Benefit Autism Speaks 2Health News:Toys'R'Us Kicks Off Fundraising Campaign to Benefit Autism Speaks 3Health News:Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: